Related Experiment Video
Updated: Jul 26, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Risk factors characterisation for CHD: a case-control study in Bogota and Cali, Colombia, 2002-2020
Esteban Portilla R1, Vyara Harizanov1, Karen Sarmiento2
1Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
Insights
Congenital heart defects (CHDs) are a major cause of infant mortality. Advanced parental age, diabetes, and lower education increase CHD risk, while folic acid intake offers protection.
Area of Science:
- Pediatrics
- Public Health
- Genetics
Background:
- Congenital heart defects (CHDs) represent 28% of congenital anomalies and are the primary cause of infant mortality.
- Early identification of risk factors for CHDs is crucial for population-level case detection and intervention.
Purpose of the Study:
- To investigate risk and protective factors associated with the presentation of congenital heart defects (CHDs).
- To inform public health strategies for reducing CHD incidence and improving patient outcomes.
Main Methods:
- Analysis of a cohort from the Program for the Prevention and Monitoring of Congenital Defects in Bogota and Cali (2002-2020).
- Classification of CHDs into isolated, complex isolated, polymalformed, and syndromic categories.
- Comparison of case and control averages using Student's t-test at a 95% confidence level.
Main Results:
- Prevalence of CHDs was 19.36 per 10,000 live births, with non-specified CHD, ventricular septal defect, and atrial septal defect being most common.
- Identified risk factors include advanced parental age (>45 years), pregestational diabetes, maternal BMI > 25, low educational level, and socioeconomic status.
- Folic acid consumption during the first trimester and pregestational period emerged as protective factors.
Conclusions:
- Several risk and protective factors significantly influence the occurrence of CHDs.
- Public health initiatives should focus on mitigating exposure to identified risk factors.
- Enhanced monitoring of high-risk individuals is recommended to improve CHD diagnosis and prognosis.
Objective:
CHDs correspond to 28% of all congenital anomalies, being the leading cause of infant mortality in the first year of life. Thus, it is essential to explore risk factors for CHDs presentation, allowing the detection of probable cases within a population.
Methods:
We identified newborns with CHDs within a cohort from the Program for the Prevention and Monitoring of Congenital Defects in Bogota and Cali, 2002-2020. Cases were classified as isolated, complex isolated, polymalformed, and syndromic. Variables were analysed by comparing case and control averages with Student's t test using a 95% confidence level.
Results:
Prevalence obtained was 19.36 per 10 000 live births; non-specified CHD, ventricular septal defect, and atrial septal defect were the most prevalent. As risk factors were found: paternal and maternal age above 45 years, pregestational diabetes, mother's body mass index above 25, low educational level, and socio-economic status. As protective factors: folic acid consumption within the first trimester and pregestational period.
Conclusion:
Different risk and protective factors associated with the presentation of CHDs have been described. We consider that public health strategies should be aimed to reduce risk factors exposure. Also, improving diagnosis and prognosis by having a close monitoring on high-risk patients.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Bias in Epidemiological Studies
Coronary Artery Disease II: Pathophysiology
Confounding in Epidemiological Studies